AAAAAA

   
Results: 1-9 |
Results: 9
Phenylbutyrate attenuates the expression of Bcl-X-L, DNA-PK, caveolin-1, and VEGF in prostate cancer cells
Authors: Goh, M Chen, F Paulsen, MT Yeager, AM Dyer, ES Ljungman, M
Citation: M. Goh et al., Phenylbutyrate attenuates the expression of Bcl-X-L, DNA-PK, caveolin-1, and VEGF in prostate cancer cells, NEOPLASIA, 3(4), 2001, pp. 331-338
High dose chemotherapy without hematopoietic cell support for the treatment of refractory lymphoma
Authors: Lonial, S Jones, TW Devine, S Winton, EF Heffner, LT Smith, KJ Yeager, AM Waller, EK
Citation: S. Lonial et al., High dose chemotherapy without hematopoietic cell support for the treatment of refractory lymphoma, LEUK LYMPH, 36(5-6), 2000, pp. 497-502
CD40 ligand upregulates expression of the IL-3 receptor and stimulates proliferation of B-lineage acute lymphoblastic leukemia cells in the presence of IL-3
Authors: Zhou, M Gu, L Holden, J Yeager, AM Findley, HW
Citation: M. Zhou et al., CD40 ligand upregulates expression of the IL-3 receptor and stimulates proliferation of B-lineage acute lymphoblastic leukemia cells in the presence of IL-3, LEUKEMIA, 14(3), 2000, pp. 403-411
Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells
Authors: Boyer, MW Waller, EK Bray, RA Unangst, T Johnson, TS Phillips, C Jurickova, I Winton, EF Yeager, AM
Citation: Mw. Boyer et al., Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells, LEUKEMIA, 14(3), 2000, pp. 412-418
Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia
Authors: Zhou, M Gu, L Abshire, TC Homans, A Billett, AL Yeager, AM Findley, HW
Citation: M. Zhou et al., Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia, LEUKEMIA, 14(1), 2000, pp. 61-67
Bone marrow transplantation for infantile ceramidase deficiency (Farber disease)
Authors: Yeager, AM Uhas, KA Coles, CD Davis, PC Krause, WL Moser, HW
Citation: Am. Yeager et al., Bone marrow transplantation for infantile ceramidase deficiency (Farber disease), BONE MAR TR, 26(3), 2000, pp. 357-363
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors
Authors: Nash, RA Antin, JH Karanes, C Fay, JW Avalos, BR Yeager, AM Przepiorka, D Davies, S Petersen, FB Bartels, P Buell, D Fitzsimmons, W Anasetti, C Storb, R Ratanatharathorn, V
Citation: Ra. Nash et al., Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors, BLOOD, 96(6), 2000, pp. 2062-2068
Impact of bone marrow transplantation for symptomatic sickle cell disease:an interim report
Authors: Walters, MC Storb, R Patience, M Leisenring, W Taylor, T Sanders, JE Buchanan, GE Rogers, ZR Dinndorf, P Davies, SC Roberts, IAG Dickerhoff, R Yeager, AM Hsu, L Kurtzberg, J Ohene-Frempong, K Bunin, N Bernaudin, F Wong, WY Scott, JP Margolis, D Vichinsky, E Wall, DA Wayne, AS Pegelow, C Redding-Lallinger, R Wiley, J Klemperer, M Mentzer, WC Smith, FO Sullivan, KM
Citation: Mc. Walters et al., Impact of bone marrow transplantation for symptomatic sickle cell disease:an interim report, BLOOD, 95(6), 2000, pp. 1918-1924
Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWiST analysis of the Pediatric Oncology Group study 8821
Authors: Parsons, SK Gelber, S Cole, BF Ravindranath, Y Ogden, A Yeager, AM Chang, M Shuster, J Weinstein, HJ Gelber, RD
Citation: Sk. Parsons et al., Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWiST analysis of the Pediatric Oncology Group study 8821, J CL ONCOL, 17(7), 1999, pp. 2144-2152
Risultati: 1-9 |